Acute XR
Pre Seed Round in 2024
Acute XR is a company that focuses on developing innovative virtual reality therapy games aimed at enhancing mental health. By creating immersive game worlds that blend therapeutic practices with engaging gameplay, Acute XR enables medical professionals to deliver treatment in an enjoyable and motivating manner for patients. The company's offerings are designed to transport users to captivating digital environments, facilitating relaxation and promoting well-being through interactive experiences.
Rhythmm AI
Pre Seed Round in 2024
Rhythmm AI is transforming healthcare administration with its AI-powered prior permission software, which intelligently automates tedious paperwork, research, and approvals.
TSP Therapeutics
Pre Seed Round in 2024
TSP Therapeutics is a registration-stage oncology firm developing and commercializing histamine signaling therapeutics to be used in conjunction with immunotherapies to help save the lives of cancer patients who are resistant to immunotherapy.
TeachMeNow
Pre Seed Round in 2024
TeachMeNow is a digital health company that uses artificial intelligence to help patients understand their medical data, particularly blood test results. Its platform provides secure storage and clear explanations of test results, aiming to address issues like high readmission rates and health illiteracy in the healthcare industry.
Delta Robotics
Pre Seed Round in 2024
Delta Robotics is developing revolutionary Nitinol artificial muscle technology to transform the robotics and prosthetics industries.
MucoLife Therapeutics
Pre Seed Round in 2024
MucoLife Therapeutics is focused on developing innovative therapies for Chronic Obstructive Pulmonary Disease (COPD) and other chronic respiratory conditions. The company specializes in creating first-in-class mucolytic medicines designed to alleviate mucus congestion in the airways. By employing unique mechanisms of action, MucoLife Therapeutics aims to improve lung function and enhance patient outcomes by reducing inflammation and preventing infections associated with pulmonary mucus obstruction. Through these targeted treatment strategies, the company seeks to transform the therapeutic landscape for individuals suffering from chronic respiratory diseases.
SensArs
Seed Round in 2024
SensArs specializes in medical equipment manufacturing, focusing on neuromodulation solutions. Its flagship product, SENSY, is an innovative healthcare technology system designed to restore natural sensations to the feet for patients who have undergone amputations or suffer from nerve damage due to diabetic neuropathy.
ClearSight Therapeutics
Pre Seed Round in 2024
ClearSight Therapeutics is a biotechnology company specializing in the development of innovative pharmaceuticals and medical devices for ophthalmology. The company's core focus is on creating novel therapies for common eye conditions, with a unique approach to treating microbial infections. Unlike traditional antibiotics, ClearSight's proprietary compounds stimulate the body's innate immune response, offering a broader spectrum of effectiveness against various infections and promoting tissue repair.
Keyron is a preclinical-stage medical device and technology platform company focused on developing innovative solutions for the treatment of metabolic diseases. The company has created a patented device called ForePass, which aims to safely reverse conditions such as type 2 diabetes, non-alcoholic steatohepatitis (NASH), and obesity. Preliminary animal studies have shown promising results, including a complete reversal of insulin resistance, with findings published in The Lancet EBioMedicine. Keyron's approach combines endoscopically implantable medical devices that replicate surgical procedures, such as sleeve gastrectomy and gastric bypass, thereby offering a minimally invasive alternative to traditional bariatric surgery. The company plans to initiate clinical trials in South America prior to expanding its efforts to the United States.
Mind+ focuses on Latina women experiencing high-risk pregnancies. The company hopes to enhance outcomes by utilizing telemedicine emotional and behavioral assistance.
WellnessWits
Seed Round in 2023
WellnessWits develops a digital platform for managing group-based health consultations and chronic condition monitoring. The platform supports virtual and in-person group appointments, facilitates collaboration among healthcare professionals, and provides tools to organize shared medical sessions.
Freezenit
Seed Round in 2023
Freezenit develops non-toxic head lice treatments suitable for all hair types. By replacing traditional pesticide-based remedies with safe formulations, the company aims to provide a safer, more convenient option that can shorten treatment time and appeal to consumers seeking effective head lice management without pesticides.
Nexterra Medical
Seed Round in 2023
Nexterra Medical specializes in developing clean technology solutions aimed at enhancing safety in medical environments. Their primary product is a mobile device designed to destroy contaminated needles and eliminate blood-borne pathogens, thereby reducing the risk of accidental needle injuries and associated liabilities.
DNASafe
Seed Round in 2023
DNA Safe is a business-to-business Software-as-a-service platform that allows healthcare firms to execute analytics on encrypted data.
OncoSwab
Seed Round in 2023
OncoSwab is focused on developing a point-of-care test designed to detect lung cancer in high-risk individuals. The company aims to improve the accessibility of lung cancer screening, thereby enhancing early detection rates. Its screening test is characterized by being minimally invasive and highly sensitive, allowing for the identification of cancer cells at an earlier stage than traditional methods. This innovation enables patients to receive timely diagnosis and treatment, potentially improving outcomes for those at risk of lung cancer.
MedKitDoc
Seed Round in 2023
MedKitDoc is a developer of a comprehensive remote medical care platform that facilitates consultations and treatments through video calls and connected medical devices. This innovative approach allows patients to engage with doctors for examinations and healthcare advice from the comfort of their homes. By leveraging real-time health data transfer, MedKitDoc enhances the management of serious chronic conditions, potentially reducing unnecessary hospitalizations by up to 50 percent. The platform is capable of addressing 48 out of the 50 most common diseases, significantly expanding the range of medical issues that can be effectively managed remotely. MedKitDoc collaborates with various care providers to improve outcomes for chronically ill patients, demonstrating its commitment to enhancing healthcare accessibility and quality.
HealthiatRx
Seed Round in 2023
HealthiatRx is a technology company focused on streamlining healthcare operations. It develops a digital platform that automates and simplifies various administrative tasks, such as digital prescriptions, revenue cycle management, prior authorizations, and claims processing. This enables healthcare organizations to reduce costs, improve efficiency, and make better business decisions.
D&P Bioinnovations
Seed Round in 2023
D&P Bioinnovations develops an implantable, bioresorbable medical device designed to regenerate a damaged esophagus. Their technology uses unique biomaterials and immunomodulatory stem cell factors, enabling treatment for esophageal cancer patients and pediatric cases involving long gap atresia or caustic ingestion.
Beam Wellness
Seed Round in 2023
Beam Wellness is a manufacturer specializing in low-level light therapy, primarily red light therapy, designed to improve skin health and appearance. Their products aim to accelerate healing, promote cleaner skin, and mitigate signs of aging, thereby enhancing overall skin wellness.
OUI Medical
Pre Seed Round in 2023
Founded in 2021, OUI Medical specializes in developing, manufacturing, and distributing innovative medical devices. Its flagship product, the P-Scope, is a non-invasive, cost-effective device designed for abdominal cavity examinations under local anesthesia in an outpatient setting. Targeting global secondary and tertiary level hospitals, OUI Medical aims to partner with large OEMs for market penetration and has set a goal of selling 500,000 units at $2,000 each within five years.
Aptus.Life
Seed Round in 2022
Aptus. Life provides and bills organizations that want to meet regulations, build their practice, and keep patients in great care. Aptus ensures compliance, enhances the patient experience and maximizes reimbursements by focusing on the strategy to effect positive change.
VenoVision
Seed Round in 2022
VenoVision develops a contactless, AI-driven cardiopulmonary monitoring platform that uses thermal imaging and machine learning to non-invasively assess hemodynamic status. This helps healthcare professionals detect patient deterioration earlier, improve care, reduce ICU admissions, and lower hospital readmissions.
alviss.ai
Seed Round in 2022
Alviss.ai is a developer of an advanced cardiovascular disease prediction platform aimed at interventional cardiologists and heart surgeons. The platform leverages artificial intelligence to analyze cardiovascular computed tomography angiography scans, identifying prognostic patterns that assist clinicians in delivering personalized treatment plans. This technology is particularly beneficial for patients undergoing transcatheter aortic valve replacement procedures, as it has the potential to reduce surgical complications and improve patient outcomes. Through its innovative approach, Alviss.ai enhances the decision-making process in cardiovascular care.
Kioma is a design and manufacturing company specializing in baby car seats. The company aims to revolutionize travel for infants by incorporating innovative materials, specifically carbon fiber, into its products. This choice of material provides several advantages, including impact absorption, ease of handling, and simplified cleaning processes. By focusing on safety and convenience, Kioma enhances the overall experience for both parents and their children.
QuantiFace
Seed Round in 2022
AI-Based consultation App for Aesthetic Practitioners
Ultrasonic Medical Mapping
Seed Round in 2022
Ultrasonic Medical Mapping develops medical mapping technology that applies aerospace-derived mapping and ultrasonic techniques to cancer detection, with a focus on pancreatic cancer. The platform aims for radiation-free, lower-cost detection capable of identifying smaller tumors than current imaging and non-imaging methods, supporting earlier intervention and potentially improved patient outcomes.
A LaRue Company
Seed Round in 2021
Founded in Winston-Salem, North Carolina in 2019, A LaRue Company specializes in the development of innovative medical devices. Their flagship product is designed to safely remove gelatinous materials and similar substances from surgical sites, minimizing biohazard exposure for surgeons and promoting less invasive procedures for patients.
Aliform
Seed Round in 2021
Aliform develops innovative medical devices aimed at improving skin surgery procedures. Their flagship product, Celluleaf, enables clinicians to treat skin connective tissue defects in a minimally invasive manner.
Sovrinti
Seed Round in 2021
Sovrinti is a developer of innovative home sensing systems focused on identifying behavior patterns that may signal significant health conditions. The company utilizes a suite of non-video and non-audio smart home sensors, combined with real-time location data, to create personalized baseline behavior profiles. This technology is particularly beneficial for monitoring aging individuals, allowing for earlier clinical diagnoses and interventions. By enhancing person-centered home care, Sovrinti aims to improve health outcomes while reducing associated costs.
RECORNEA
Seed Round in 2021
Recornea is a company focused on developing a corneal medical device aimed at restoring the natural curvature of the cornea, providing clear and predictable clinical outcomes. Their technology involves an implantable medical solution designed to improve vision for patients with keratoconus and other conditions that deform the cornea. This approach enables healthcare professionals to effectively treat various pathological conditions affecting the cornea.
Oral Genome
Seed Round in 2021
Oral Genome is a health and wellness company specializing in oral care. It offers a dental testing kit that analyzes an individual's mouth microbiome and biomarkers, providing personalized insights to help prevent oral diseases and common dental issues.
Parrots
Seed Round in 2021
Parrots is a medical devices company developing an assistive technology platform and socially assistive robots that support people with mobility and cognitive or neurological challenges. Its Polly system acts as a friendly companion that enables real-time communication and interaction, with hands-free control through eye-tracking and other input methods. The platform combines AI-powered prediction for communication, 360-degree computer vision for indoor and outdoor use, and connectivity with smart-home devices, while supporting various input switches and accessories. It also provides health monitoring capabilities, tracking vital signs and health metrics to aid independence and reduce caregiver burden. The solution aims to enhance independence for physically disabled users, facilitate communication, and assist caregivers through integrated apps and devices.
Sympal is a clear aligner company focused on enhancing orthodontic care by making it safer, more effective, and affordable for patients. Unlike other direct-to-consumer aligner brands, Sympal requires orthodontic clearance from a dentist, ensuring that treatment is overseen by a doctor through a real-time tracking system. This approach not only corrects the bite but also treats the underlying causes of crooked teeth, offering a solution that addresses more cases than typical aligners. Founded by experienced dental entrepreneurs, Sympal's team comprises skilled dentists, orthodontists, and engineers with a proven track record in launching successful dental innovations. By providing a patient-centric approach at half the cost of conventional options, Sympal aims to simplify the teeth-straightening process while delivering quality care.
AllergenIQ
Pre Seed Round in 2021
AllergenIQ provides virtual allergy care services, offering personalized treatment plans, prescription delivery, and ongoing support from licensed allergists. This enables patients to conveniently manage their allergies at home.
Health Haven Rx
Seed Round in 2020
Health Haven Rx is building the future of digital pharmacy services. We are on a mission to make pharmacy services more affordable while delivering quality care
Colonai
Seed Round in 2020
ColonaAI is a medical device company focused on enhancing colorectal cancer screening through advanced technology. The company has developed an artificial intelligence-enabled platform that aids physicians in detecting and removing colorectal tumors more effectively. Its software is designed to identify missed and incompletely removed polyps, as well as detect lesions in the small bowel, ultimately aiming to reduce mortality associated with colorectal cancer. By optimizing physician workflow, ColonaAI strives to improve patient outcomes and advance the field of cancer detection and treatment.
Iluria is a digital health company focused on ADHD management, offering a SaaS platform that supports physicians and families in treatment decisions. The system uses a machine learning and deep learning engine to provide personalized, objective, real-time outputs through a professional web application for clinicians and a mobile app for parents. It enables continuous and passive monitoring based on biomarker data from wearable devices, helping move beyond the traditional trial-and-error approach. Founded in 2018 and based in Hod Hasharon, Israel, Iluria aims to streamline evaluation and decision making in ADHD treatment by integrating data-driven insights into everyday care.
Loop Dx
Seed Round in 2020
Loop Dx is developing point-of-care diagnostics for faster detection of sepsis to reduce sepsis mortality, patient side effects, and antibiotic resistance due to unnecessary provided antibiotics. We want to facilitate healthcare providers the tools they need for faster sepsis identification saving lives and optimizing sepsis management.
Spectrum Disinfection
Seed Round in 2020
Founded in Denver, Colorado in 2018, Spectrum Disinfection specializes in manufacturing innovative disinfectant solutions. The company's patented process stabilizes Chlorine Dioxide, a highly effective industrial disinfectant, for use as a liquid surface disinfectant without the environmental drawbacks of traditional disinfectants.
Karyosoft
Seed Round in 2020
Founded in 2020, Karyosoft develops software solutions tailored for biotechnology and academia. Its flagship product, Loci, is a web-based platform that streamlines microbial genome sequence data management, analysis, and visualization. The company also offers custom software development services and consulting to optimize workflows in agricultural biotechnology.
Firstlook
Seed Round in 2020
Firstlook specializes in intelligent automation solutions for the healthcare industry. Its online platform employs artificial intelligence to analyze healthcare data and predict medical needs, enabling providers to enhance labor efficiency and improve patient outcomes.
Noleus Technologies
Seed Round in 2019
Noleus Technologies develops a novel medical device that accelerates patient recovery after abdominal surgery by preventing post-operative ileus and intestinal wall edema. This reduces length of stay for patients, saving time for physicians and costs for hospitals.
Halo Health Systems
Seed Round in 2019
Halo Health Systems is a healthcare company dedicated to enhancing patient care through innovative technology. The company has developed a medical-grade wearable device that is worn on the upper arm, enabling continuous monitoring of vital signs such as blood pressure, respiratory rate, heart rate, mobility, oxygen saturation, temperature, and perspiration. This tool is designed to assist healthcare providers in swiftly identifying patients at high risk of acute health deterioration, both at home and in hospital settings. By focusing on patient-centric trials, Halo Health Systems aims to reduce the burden on patients and healthcare locations, thereby improving overall healthcare outcomes.
OneSeventeen Media
Seed Round in 2019
Founded in 2008 and based in Austin, Texas, OneSeventeen Media develops digital tools promoting children's mental well-being. Its flagship product, MyMobileMentor, empowers kids to manage life challenges through skill-building. The company also offers an integrated behavior management system for schools.
Perinatal Access
Pre Seed Round in 2019
Perinatal Access is a digital health company specializing in remote perinatal care. It operates a telemedicine platform that connects pregnant individuals and their families with specialist healthcare providers, regardless of location. The platform facilitates video consultations and live ultrasound streaming, aiming to provide convenient, accessible care while reducing travel-related stress.
Founded in 2018, Aurie is a medical device company specializing in reusable urinary catheterization systems. Its flagship product is a portable, battery-operated case that washes, dries, and stores catheters, enabling individuals with mobility or neurological conditions to perform safe and independent urinary care.
Health Haven Rx
Seed Round in 2019
Health Haven Rx is building the future of digital pharmacy services. We are on a mission to make pharmacy services more affordable while delivering quality care
VasoGnosis
Seed Round in 2019
Founded in 2019, VasoGnosis is a Milwaukee-based healthcare technology company specializing in AI-powered diagnostic and surgical planning software for cerebrovascular diseases like brain aneurysms. Its platform automates analysis of brain aneurysms, providing advanced visualization tools to aid neurosurgeons and interventional neuroradiologists in decision-making.
Vitrix Health
Pre Seed Round in 2019
Vitrix Health, Inc. is a company that designs, develops, and manufactures innovative screening tools for the healthcare industry, specifically focusing on early-stage detection of oral diseases and cancers. Founded in 2018 and headquartered in Champaign, Illinois, Vitrix Health utilizes a combination of optics and machine learning on a mobile platform to enhance the effectiveness of oral health screenings conducted by primary care providers. This technology addresses the significant number of Americans who do not visit dentists regularly, thereby improving overall health outcomes and reducing costs. The company's oral cancer screening device is currently undergoing pilot testing in various prestigious institutions, including Mt. Sinai Hospital and the University of Chicago Medical School, in addition to international clinical trials in Bolivia and India. By empowering primary care providers to detect oral diseases, Vitrix Health aims to bridge disparities in oral health and ensure timely referrals for dental care.
Stingray Therapeutics
Seed Round in 2018
Stingray Therapeutics, established in 2018 and headquartered in Houston, Texas, is a biotechnology company dedicated to developing immunotherapies for the treatment of diverse types of cancer. Their portfolio includes oral medications designed to stimulate innate immunity modulators via interferon gene pathways, employing potent and selective small molecule inhibitors that can be integrated into every cell, thereby enabling clinicians to harness a robust immune system response against cancer.
Runnur is a developer of Sentiv, a fitness incentive app that provides its users with the causefit platform helping them to reach their fitness goals.
It was founded in May 2016.
MycoDART
Seed Round in 2018
MycoDART develops molecular diagnostic tests for rapid detection of deadly infections, focusing on fungal pathogens. The company creates diagnostic panels that use dual amplification real-time PCR formats and run on common hospital equipment, compatible with whole blood, plasma, and bronchoalveolar lavage samples to enable timely identification of infections. Its product portfolio includes Candida panels for invasive candidiasis and Aspergillus panels, with plans to extend to other fungi such as Mucor. Founded in 2018 and based in Carrollton, Texas, MycoDART aims to improve early detection, reduce mortality, and lower treatment costs for immunocompromised patients such as transplant recipients and cancer patients by providing reliable, rapid tests.
Sppare.me is a sperm cryopreservation service provider.
Clikrx
Pre Seed Round in 2018
ClikRx is a digital health company that specializes in streamlining the integration of local healthcare providers into hospital medical record systems. By creating a network that allows doctors to efficiently route patients based on their insurance and required services, ClikRx enhances the referral process. Its platform features a user-friendly graphical interface that simplifies the prescribing of durable medical equipment, enabling physicians to manage referrals and orders from a single location. The system prioritizes patient data security, ensuring that sensitive information is protected during the referral process. Through its innovative solutions, ClikRx aims to improve the overall efficiency of healthcare delivery.
VenoStent
Seed Round in 2017
VenoStent develops bioabsorbable smart polymer wraps for vascular surgeries. Its flagship product, SelfWrap, is a perivascular wrap designed to reduce failures at the vein-artery junction in dialysis patients by promoting outward vein growth and providing custom-fit mechanical support. The company's technology acts as an external stent, reducing surgery time, infection risk, and wound reopening while improving vein usability and durability.
Benefizz
Seed Round in 2017
Founded in Memphis, Tennessee in 2015, Benefizz produces and sells all-natural, probiotic soda beverages with less than five grams of sugar per bottle. Their products are lightly carbonated, contain live probiotic cultures, and are flavored with organic fruits, providing a non-dairy, low-sugar alternative for digestive health support.
Frameri
Seed Round in 2017
Frameri, Inc. is a manufacturer and retailer of prescription eyewear, specializing in interchangeable lenses and frames for both men and women. Established in 2013 and based in Cincinnati, Ohio, the company provides a diverse selection of eyeglasses and sunglasses available in various sizes and colors. Frameri's business model allows customers to mix and match lenses with different frame designs, offering flexibility and personalization in eyewear. The company operates a retail location in Cincinnati and collaborates with other retailers across several states, including North Carolina, Texas, and California. Additionally, Frameri offers its products through an online platform, enabling consumers to purchase lenses and frames separately.
Buck Brush
Seed Round in 2017
Buck Brush markets and sells electric toothbrushes with a monthly subscription of replacement heads for only a dollar each
Ataia Medical
Seed Round in 2017
Ataia Medical, established in 2017 by biomedical engineers and critical care physicians, focuses on creating innovative communication solutions for patients who are unable to speak due to the use of hard plastic hospital masks. The company develops a medical device and communication system that facilitates interaction between patients and their physicians, caregivers, and family members. This intuitive communication aid enables patients undergoing non-invasive ventilation and oxygen therapies in critical care settings to effectively convey their needs and thoughts, thereby enhancing their overall care experience.
Gregor Diagnostics
Pre Seed Round in 2017
Gregor Diagnostics Inc. is a molecular diagnostics company dedicated to developing innovative screening tests for prostate cancer. Founded in 2016 and headquartered in Madison, Wisconsin, the company has created a technology that utilizes seminal fluid as a sample source. This advanced testing method enables the early detection of prostate cancer and helps differentiate between indolent and aggressive forms of the disease. By providing a reliable assessment of cancer aggressiveness, Gregor Diagnostics aims to assist physicians in reducing the risks of overdiagnosis and overtreatment of less severe cases while enhancing the management of more aggressive prostate cancer.
Nobo
Pre Seed Round in 2017
Nobo, Inc. is focused on the development of a connected wearable device that monitors hydration levels for elite athletes and health-conscious individuals. Based in Milwaukee, Wisconsin, the company employs patent-pending, non-invasive optical technology that uses near-infrared light to assess hydration and other important biometrics. By illuminating specific areas of the body and measuring the light returned, Nobo's device provides real-time data on total water content and various health metrics. This innovation aims to enhance the understanding of hydration for athletes, trainers, clinicians, and individuals in challenging environments or healthcare settings, fostering improved health and performance outcomes.
Articulate Labs
Seed Round in 2017
Founded in 2009 and based in Austin, Texas, Articulate Labs develops wearable medical devices that enhance joint rehabilitation. Their primary product, KneeStim, uses neuromuscular electrical stimulation to strengthen knee muscles during everyday movement, aiding in the treatment of knee osteoarthritis.
Insight Optics
Pre Seed Round in 2016
Insight Optics is an impact-driven startup focused on enhancing the connection between primary care providers (PCPs) and local specialists for assisted diagnostics in preventive healthcare. The company has developed a telemedicine platform that enables PCPs to record and refer retinal exams to specialists, facilitating the early detection of diseases such as retinopathy and glaucoma. By utilizing mobile imaging technology and machine learning, Insight Optics ensures that the captured content is of diagnosable quality, allowing untrained individuals to participate in the process. This approach targets the significant number of patients, particularly in rural and underserved areas, who are recommended for annual retinal exams but often do not receive them due to barriers such as accessibility and specialist availability. The platform not only improves patient care but also creates new revenue streams for PCPs through reimbursements and government incentives, while helping specialists increase their patient screening capacity without necessitating in-person visits. Overall, Insight Optics aims to empower healthcare providers to deliver timely interventions, thereby reducing the risk of preventable diseases among at-risk populations.
Provider of a health system to connect providers with clients. The company's application offers behavioral health system allows providers to access critical data that can be used to improve treatment and outcomes engagement.
MediBookr
Pre Seed Round in 2016
MediBookr is an innovative patient engagement and navigation platform that enhances the interaction between patients, healthcare providers, and health plans. The company offers a comprehensive online solution that allows patients to search for rated imaging centers, obtain price quotes, and book appointments with ease. MediBookr's technology is designed to facilitate transparent communication between health plans and patients while providing flexible engagement tools for employers and providers. By optimizing the delivery of virtual care, the platform aims to reduce overall healthcare costs and improve outcomes for patients. Additionally, MediBookr offers consulting, hosting, and advocacy services to further support its users in navigating the healthcare system effectively.
Optonome
Seed Round in 2016
Optonome is a healthcare technology company that specializes in enhancing the operations of home and community providers, particularly for individuals with disabilities and seniors seeking to age in place. The company has developed a unique model that focuses on community-based services and aims to create a network of clinician-owned home healthcare agencies. These boutique agencies, managed by nurses and therapists, are positioned to deliver high-quality care at affordable prices. Optonome's application serves as a comprehensive coordination system, connecting clinicians, families, and support professionals while streamlining care delivery and fostering community engagement. With a network of over 150 clinician-owned agencies across the United States, Optonome is dedicated to promoting independence and meaningful living for its clients. The company is also poised to generate significant social impact, with projections indicating over $330 million in contributions over the next three years, including increased wages for care workers and affordable supportive housing for vulnerable populations. This innovative approach distinguishes Optonome from traditional healthcare models, highlighting its commitment to effective and compassionate care.
HealthNextGen
Seed Round in 2016
HealthNextGen operates a comprehensive digital platform designed to enhance communication and coordination among various stakeholders within the healthcare ecosystem. The company's core offering is an online software solution that facilitates connections between patients and healthcare service providers, while also providing tools for tracking prescription adherence, analyzing patient records, identifying reimbursement gaps, predicting clinical outcomes, and reducing overall healthcare costs. This platform empowers patients with access to relevant medical care information and pricing transparency.
HealPal
Seed Round in 2016
HealPal Inc. operates an online platform designed for cancer patients and their families, facilitating access to essential information and community support. The platform, known as HealPal, offers resources related to various cancer treatments, including chemotherapy, immunotherapy, and targeted therapy, among others. It enables users to connect with fellow patients, learn about clinical trials, and receive recommendations on the latest medical discoveries. Additionally, HealPal provides educational content through easy-to-understand infographics and videos, helping patients navigate their treatment options and communicate effectively with healthcare providers. Based in Sunnyvale, California, HealPal aims to enhance the healthcare experience for cancer patients by fostering collaboration and informed decision-making.
ClinicalSolutions.io
Pre Seed Round in 2016
ClinicalSolutions.io is an online platform designed to connect individuals seeking clinical trials with medical researchers. By creating a medical profile, users can easily find and apply for clinical trials that match their specific conditions. The platform aims to streamline the process of connecting clinical trial volunteers with researchers, enhancing efficiency and security. With a vision to eliminate orphan diseases by 2050, ClinicalSolutions.io is committed to facilitating meaningful connections in the medical research community.
Sentinel Diagnostic Imaging, Inc. is a medical image analysis company that provides innovative software to improve the precision and early detection of sight-threatening retinal vascular diseases. The Oqulus analysis system computes quantitative objective metrics characterizing the structure and health of the retinal vasculature from standard digital photographic images of the retina.
INRFOOD
Seed Round in 2015
INRFOOD, Inc., established in 2011 and based in Durham, North Carolina, develops websites and mobile applications aimed at helping users make informed dietary decisions. Their platform allows users to discuss and share information about their diet, view advanced analytics of their eating habits, and receive real-time notifications about products that may not be suitable due to various allergies or dietary restrictions such as gluten, milk, peanut, shellfish, soy, tree nut, vegan, vegetarian, diabetic, heart condition, pregnant, egg allergy, fish allergy, corn allergy, and wheat allergy. The company offers the INRFOOD APP, which provides detailed food information, and Sugar Cube, an application that helps users visualize sugar content in their food using teaspoons, packets, and sugar cubes. These applications are available through iTunes, Google Play, and App Store.
Exhale Advisors
Seed Round in 2015
Exhale Advisors was founded in 2017 with a single mission: to massively improve the access, quality and cost of the US healthcare system. We approach each of our clients with fresh eyes and develop strategies that will accelerate your growth.
Flow MedTech
Seed Round in 2015
Flow MedTech is a medical device company specializing in innovative solutions for cardiovascular physicians operating within hospital settings. Their primary product is a novel medical stimulation device designed to prevent strokes in patients with irregular heartbeat rhythms, specifically those with atrial fibrillation. This device reduces stroke risk by preventing clot formation in the left atrial appendage, enabling healthcare providers to offer efficient treatment and promote faster patient recovery from cardiac disorders.
Dynofit
Seed Round in 2015
Dynofit, Inc. is a technology company that develops applications and software to enhance physical therapy through the integration of sensors and mobile technologies. Founded in 2012 and headquartered in Los Alamos, New Mexico, Dynofit focuses on making rehabilitation accessible in home settings for individuals suffering from neuro-muscular impairments due to conditions such as stroke, cerebral palsy, and spinal cord injuries. One of its key offerings is a mobile application and clinical dashboard known as DOTs, which utilizes electromyography (EMG) biofeedback to measure, digitize, and store therapy-related data. This system aims to increase patient engagement and provide therapists with valuable insights into patient progress between clinical visits, ultimately enhancing the overall effectiveness of therapeutic interventions.
md Portal
Seed Round in 2015
md Portal is a telemedicine platform designed for dermatologists and other specialists, enabling them to efficiently manage patient care through online consultations. The platform facilitates asynchronous visits by allowing patients to complete questionnaires and submit photos, streamlining the process for both providers and patients. By offering cloud-based services, website integration, and payment solutions, md Portal enhances clinic workflows while maintaining HIPAA-compliant security. This technology empowers healthcare providers to deliver high-quality follow-up care and attract new patients, ultimately contributing to the growth of their practices.
DUALAMS
Seed Round in 2015
DUALAMS is a medical device developer focused on enhancing patients' pre-and post-operative experiences. The company has created a medical instrument that enables the injection of nebulized lidocaine, which facilitates examinations by reducing reflex responses such as gagging, coughing, aspiration, bucking, and laryngospasm. This innovation allows clinicians to conduct procedures more efficiently. DUALAMS holds two pending patents, with one that ultrasonically nebulizes local anesthetics and targets specific delivery points within the vocal anatomy. The second patent involves the use of ultrasound to nebulize medical substances, directing them to specific areas of the body that can be accessed via flexible endoscopes.
Obaa Inc. is a healthcare company based in Cambridge, Massachusetts, that operates a platform designed to connect primary care providers with specialists through video consultations. The company offers a solution called Prime by OBaa, which aims to reduce wait times and ensure timely access to care for patients. Additionally, Obaa provides Peach by Obaa, a mobile electronic medical records (EMR) solution that allows healthcare providers to access patient information seamlessly without the need for complex integrations. The platform also includes features specifically tailored for expectant mothers, enabling them to consult with lactation consultants and obstetricians conveniently. Through these services, Obaa enhances patient engagement and improves healthcare delivery.
Noninvasix
Seed Round in 2015
Noninvasix, Inc., established in 2007, is a medical technology company based in Galveston, Texas. It develops non-invasive precision oximetry systems designed to measure oxygen sufficiency within organs and veins without the need for invasive catheters. The company's primary focus is on monitoring brain oxygenation in preterm babies within newborn intensive care units (NICUs). Noninvasix has raised over $6.8 million in funding, including a seed round in late 2021, and has been supported by grants from the NIH and DOD totaling $6 million. The company's technology has been clinically validated and is protected by a robust IP portfolio comprising 9 U.S. and 8 global patents. Noninvasix has participated in prestigious accelerator programs such as Philips Healthworks and TMCx, and its innovations have earned multiple awards.
Cloud 9
Pre Seed Round in 2015
Cloud 9 is on a mission to disrupt massive waste and mistreatment of people with mental illness. Cloud 9’s proprietary patient-centric technology platform allows multidisciplinary care teams (including mental healthcare, primary care, substance use specialists and first responders) to communicate and share data with one another and their patients.
They keep high risk patient populations engaged in treatment to keep them out of crisis, before they land in ERs, jails, courts or the streets. Their technology and service model innovation deliver a paradigm shift that can save billions for state and local budgets, while also helping underserved individuals. The larger social impact is that healthy minds create healthier communities, workplaces, homes, and future generations.
Sintact Medical Systems
Seed Round in 2014
Sintact Medical Systems, Inc. is a medical technology company based in Bloomington, Indiana, founded in 2013. The company specializes in the development of non-resorbable films designed to prevent surgical adhesions, which are internal scar formations that cause adjacent organs and tissues to stick together following surgery. These films serve as a barrier, effectively separating organ and tissue surfaces to minimize the risk of adhesion formation and related post-operative complications. By providing a clear plane of dissection, Sintact's products also enhance the ease of re-operation when necessary, ultimately improving patient outcomes and advancing surgical practices.
Orb Health
Seed Round in 2014
Orb Health specializes in collaborative virtual care solutions that enable healthcare providers to deliver reimbursed services such as chronic care management remotely. Its platform connects existing electronic medical records with a virtual care hub, empowering remote providers to deliver care while maintaining the practice's brand and quality standards.
INRFOOD
Seed Round in 2014
INRFOOD, Inc., established in 2011 and based in Durham, North Carolina, develops websites and mobile applications aimed at helping users make informed dietary decisions. Their platform allows users to discuss and share information about their diet, view advanced analytics of their eating habits, and receive real-time notifications about products that may not be suitable due to various allergies or dietary restrictions such as gluten, milk, peanut, shellfish, soy, tree nut, vegan, vegetarian, diabetic, heart condition, pregnant, egg allergy, fish allergy, corn allergy, and wheat allergy. The company offers the INRFOOD APP, which provides detailed food information, and Sugar Cube, an application that helps users visualize sugar content in their food using teaspoons, packets, and sugar cubes. These applications are available through iTunes, Google Play, and App Store.
Silicone Arts Laboratories
Seed Round in 2014
Silicone Arts Laboratories, LLC is a Memphis, Tennessee-based company founded in 2010, specializing in the manufacture of cosmetic products aimed at enhancing physical appearances. The company is best known for its flagship product, Dermaflage, a topical scar filler that effectively conceals recessed scars and skin defects on both the face and body without the need for surgery or injections. Utilizing silicone to replicate the tone and texture of natural skin, Dermaflage offers a practical solution for individuals seeking to hide imperfections resulting from various conditions, including acne, chickenpox, bite marks, and surgical scars. In addition to Dermaflage, Silicone Arts Laboratories develops AeXP (Anatomical Eye – Experimental), a precise replica of a human eye designed for medical training and device testing.
Carevature Medical
Seed Round in 2014
Carevature Medical Ltd. is a privately held medical device company based in Rehovot, Israel, founded in 2011. The company specializes in developing innovative tools and procedures aimed at addressing orthopedic surgical needs, with a primary focus on spinal surgery and joint arthroscopy. Carevature Medical has created a proprietary device platform that enables direct decompression through an indirect approach, which helps to preserve healthy tissue, minimize trauma, and reduce both surgical time and costs. Its product offerings include disposable devices for open and mini-open spinal decompression procedures, addressing various lumbar and cervical spine conditions. Additionally, the company is actively working on introducing further advancements in the fields of spine and joint arthroscopy.
Platform Orthopedic Solutions
Seed Round in 2014
Platform has changed the way industrial manufacturing and customization come together. Using 3D scanning technologies and propitiatory modeling and optimization software, our product enables digital manufacturing of better fitting custom orthotics. The technology allows precise modification of the 3D scanned models according to morphological and spectral information as well as precise control over the material properties. Platform's technology enables the creation of custom flip-ons, sandals and sportswear as well as clinical orthotics for high risk feet patients and diabetic ulceration patients.
PureWine
Seed Round in 2014
PureWine is a company that specializes in developing innovative wine filters designed to enhance the drinking experience by reducing unwanted substances in wine. Their flagship product, The Wand®, utilizes patented nano-filtration technology to effectively remove contaminants, preservatives, and allergens such as histamines and sulfite preservatives. This process not only mitigates side effects like headaches and allergic reactions but also aims to preserve the full flavor of the wine, allowing consumers to enjoy their favorite wines without discomfort.
Coordi-Care’s
Seed Round in 2014
Software minimizes the amount of time doctors spend on menial tasks
BreathalEyes
Seed Round in 2014
BreathalEyes, Inc. is a Texas-based company that has developed a mobile application designed to measure blood alcohol content (BAC) accurately and non-invasively. Utilizing the technique of horizontal gaze nystagmus, the app tracks involuntary fluctuations of the pupil as the eye focuses on a point to the side of the face, providing a reliable assessment of intoxication levels. This innovative technology allows users to test their BAC quickly and inexpensively, addressing a critical need in preventing accidents and fatalities associated with drunk driving. The application is notable for being the first of its kind to make this method available on a smartphone device, enhancing accessibility for consumers who wish to ensure their safety and the safety of others on the road.
Lantern Pharma
Seed Round in 2014
Lantern Pharma Inc. is a clinical-stage biotechnology company based in Dallas, Texas, specializing in the development of precision oncology therapeutics through the integration of artificial intelligence, genomics, and machine learning. The company's lead drug candidate, LP-100, is currently undergoing phase II clinical trials for the treatment of metastatic, castration-resistant prostate cancer. Additionally, Lantern is advancing LP-300 as a combination therapy for female non-smokers with non-small cell lung cancer adenocarcinoma. Another promising candidate in preclinical development is LP-184, an alkylating agent targeting DNA in cancer cells that overexpress specific biomarkers. Lantern Pharma employs its proprietary RADR platform to enhance drug discovery and development, addressing challenges in patient stratification and understanding mechanisms of action, ultimately aiming to accelerate the delivery of personalized cancer therapies. The company was incorporated in 2013 and has positioned itself at the forefront of innovation in oncology.
GetFittter
Pre Seed Round in 2014
GetFittter Inc. is a technology company that provides a digital platform designed to connect health enthusiasts with professional fitness coaches. Its flagship product, fittter, is a cloud-based solution that features a web and mobile application for trainers and their clients. Trainers can manage accounts and workouts, while clients receive tailored workout plans, track their progress, and interact with training equipment through animated sequences and detailed illustrations. The platform also includes a marketplace for health programs created by selected coaches, allowing users to subscribe to digital coaching services. Additionally, fittter enhances user engagement through wearables that sync training data directly into the app. With its innovative approach, GetFittter aims to create new revenue streams for health coaches and empower individuals to achieve their fitness goals. The company is based in the United States.
Cariloop
Seed Round in 2014
Cariloop is a digital platform that connects seniors, caregivers, and healthcare providers. It offers real-time information on geriatric care services, enables providers to market their capabilities digitally, and facilitates communication among users. Incorporated in 2012, Cariloop is headquartered in Dallas, Texas.
ImageVision
Series B in 2014
ImageVision specializes in visual content recognition and monetization for social media and multimedia platforms. It offers real-time, AI-driven technology that identifies and categorizes billions of daily photos and videos, enabling clients like Apple, Facebook, and Yahoo! to enhance image search, analyze brands, tailor ads, and safeguard against inappropriate content. The company's platform also provides facial recognition and demographic insights, helping clients improve operational efficiency and brand protection.
Socrates Health Solutions
Seed Round in 2013
Socrates Health Solutions, Inc. is a Dallas-based company that develops and manufactures innovative diabetes testing devices. Their flagship product, the Companion, is a non-invasive self-monitoring device that enables users to measure blood glucose levels without the need for needles or finger pricks. This technology provides real-time data to help individuals manage their diabetes effectively, generating custom alerts for critical glucose levels and facilitating communication with mobile devices to track historical data. Founded in 2013, Socrates Health Solutions aims to enhance access to affordable diabetes care through advanced technology, allowing patients to make informed treatment decisions and reduce complications associated with the disease.
Nexeon Medsystems
Seed Round in 2013
Nexeon MedSystems is a bioelectronics company focused on developing active medical devices for chronic medical conditions. The company specializes in neuromodulation technology and aims to address disorders associated with nervous system tissues. Nexeon MedSystems integrates various fields, including electronics, software, mechanical engineering, material science, pharmaceuticals, protein chemistry, and cell biology, to create innovative solutions for patient care. Through its technology platform, the company is committed to advancing medical treatment options in the realm of neurostimulation.
Carestarter
Seed Round in 2013
CareStarter is a technology company that provides a caregiving application aimed at enhancing care management within pediatric healthcare settings. Founded in 2013 and headquartered in Austin, Texas, the platform enables Children's Hospitals, pediatric-focused health plans, specialty clinics, and federally qualified health centers to automate and scale their care management teams. By addressing the challenge of limited patient interaction, CareStarter aims to increase engagement to 100% of the patient population, achieving a noteworthy 70% adoption rate. The application allows physicians to concentrate on complex medical issues while supporting patient-centered care by delivering essential resources and information that help patients navigate their healthcare journey and make informed decisions. Additionally, CareStarter leverages social determinants of health and demographic data to mitigate risks within patient populations, contributing to the broader goals of value-based healthcare.
Physmodo
Seed Round in 2013
Physmodo operates a digital platform that assesses physical movement, aiming to enhance key aspects of health. It offers science-based screening, automated scoring, personalized corrective programs, and data tracking across devices to monitor performance, support recovery, and mitigate injury risk.
Cariloop
Seed Round in 2013
Cariloop is a digital platform that connects seniors, caregivers, and healthcare providers. It offers real-time information on geriatric care services, enables providers to market their capabilities digitally, and facilitates communication among users. Incorporated in 2012, Cariloop is headquartered in Dallas, Texas.
Make My plate
Seed Round in 2013
Make My Plate is changing the dieting world!
They present a visually appealing and fun approach to maintaining a healthy lifestyle. They are connecting the dietary ecosystem, answering the user's nutritional needs on one hand and creating a marketplace for professionals on the other.
Remind Technologies
Seed Round in 2013
Remind Technologies LLC is a medical device company that specializes in designing and developing integrated software and hardware solutions for medication adherence. Founded in 2013 and headquartered in Humble, Texas, the company has created MindRx, an innovative smartphone case that functions as a pill dispenser. This device is equipped to track and dispense medication according to customized schedules, while also recording adherence through an accompanying software application. Remind Technologies aims to enhance disease management by providing tools that help patients manage their medications effectively and incentivize adherence.